BMJ 2008;336:714-717 (29 March), doi:10.1136/bmj.39505.641273.AD
Practice
Guidelines
Management of diabetes from preconception to the postnatal period: summary of NICE guidance
The Guideline Development Group
Moira A Mugglestone, National Collaborating Centre for Womens and Childrens Health, London W1T 2QA mmugglestone@ncc-wch.org.uk
| The first 150 words of the full text of this article appear below. |
Diabetes in pregnancy is associated with risks to the woman (for example, higher rates of miscarriage, pre-eclampsia, and preterm labour) and to the developing fetus and baby (for example, higher rates of congenital malformations, macrosomia, birth injury, and perinatal mortality).1 2 This article summarises the most recent guidance from the National Institute for Health and Clinical Excellence (NICE) on how to manage diabetes and its complications from preconception to the postnatal period.3
NICE recommendations are based on systematic reviews of best available evidence. When minimal evidence is available, recommendations are based on the guideline development groups opinion of what constitutes good practice. Evidence levels for the recommendations are given in italic in square brackets.
- From adolescence onwards, advise women about the importance of avoiding unplanned pregnancy. [Based on a high quality national clinical audit]
- Inform women and their families about how diabetes affects pregnancy and how pregnancy affects diabetes . . . [Full text of this article]
Information and advice for women with diabetes and their families should cover the following pointsFor women with pre-existing diabetes information and advice should also cover the following points

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Relevant Articles
-
Commentary: Controversies in management of diabetes from preconception to the postnatal period
- Lucy C Chappell and Sarah J Germain
BMJ 2008 336: 717-718.
[Extract]
[Full Text]
[PDF]
-
Screen all pregnant women for risk factors for gestational diabetes, says NICE
- Zosia Kmietowicz
BMJ 2008 336: 689.
[Extract]
[Full Text]
-
Outcomes of pregnancy in insulin dependent diabetic women: results of a five year population cohort study
- I F Casson, C A Clarke, C V Howard, O McKendrick, S Pennycook, P O D Pharoah, M J Platt, M Stanisstreet, D van Velszen, and S Walkinshaw
BMJ 1997 315: 275-278.
[Abstract]
[Full Text]
-
Prospective population based survey of outcome of pregnancy in diabetic women: results of the Northern Diabetic Pregnancy Audit, 1994
- Gillian Hawthorne, S Robson, E A Ryall, D Sen, S H Roberts, and M P Ward Platt
BMJ 1997 315: 279-281.
[Abstract]
[Full Text]
This article has been cited by other articles:
-
Jensen, D. M., Korsholm, L., Ovesen, P., Beck-Nielsen, H., Moelsted-Pedersen, L., Westergaard, J. G., Moeller, M., Damm, P.
(2009). Peri-Conceptional A1C and Risk of Serious Adverse Pregnancy Outcome in 933 Women With Type 1 Diabetes. Diabetes Care
32: 1046-1048
[Abstract]
[Full text]
-
Simmons, D., Devers, M. C., Wolmarans, L., Johnson, E.
(2009). Difficulties in the Use of Risk Factors to Screen for Gestational Diabetes Mellitus. Diabetes Care
32: e8-e8
[Full text]
-
Kolagasi, O., Sari, F., Akar, M., Sari, R.
(2009). Normal Pregnancy and Healthy Child After Continued Exposure to Gliclazide and Ramipril During Pregnancy. The Annals of Pharmacotherapy
43: 147-149
[Abstract]
[Full text]
Rapid Responses:
Read all Rapid Responses
- WHO criteria
- Rupert Gude
bmj.com, 2 Apr 2008
[Full text]
- Mig trial
- V Gowri
bmj.com, 6 Apr 2008
[Full text]